Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Amendment history:
  • Correction (August 1970)

Research Article Free access | 10.1172/JCI106301

Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3′-L-triiodothyronine and L-thyroxine

Jack H. Oppenheimer, Harold L. Schwartz, Harvey C. Shapiro, Gerald Bernstein, and Martin I. Surks

1Endocrine Research Laboratory, Division of Medicine, Montefiore Hospital and Medical Center and Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Oppenheimer, J. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Division of Medicine, Montefiore Hospital and Medical Center and Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Schwartz, H. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Division of Medicine, Montefiore Hospital and Medical Center and Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Shapiro, H. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Division of Medicine, Montefiore Hospital and Medical Center and Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Bernstein, G. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Division of Medicine, Montefiore Hospital and Medical Center and Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Surks, M. in: PubMed | Google Scholar

Published May 1, 1970 - More info

Published in Volume 49, Issue 5 on May 1, 1970
J Clin Invest. 1970;49(5):1016–1024. https://doi.org/10.1172/JCI106301.
© 1970 The American Society for Clinical Investigation
Published May 1, 1970 - Version history
View PDF
Abstract

Administration of phenobarbital, which acts exclusively on cellular sites, results in an augmentation of the liver/plasma concentration ratio of L-thyroxine (T4) in rats but no change in the liver/plasma concentration ratio of L-triiodothyronine (T3). Whereas phenobarbital stimulates the fecal clearance rate both of T3 and T4, it increases the deiodinative clearance rate of T4 only. These findings suggest basic differences in the cellular metabolism of T3 and T4. Further evidence pointing to cellular differences was obtained from a comparison of the distribution and metabolism of these hormones with appropriate corrections for the effect of differential plasma binding. The percentage of total exchangeable cellular T4 within the liver (28.5) is significantly greater than the corresponding percentage of exchangeable cellular T3 within this organ (12.3). Extrahepatic tissues bind T3 twice as firmly as T4. The cellular metabolic clearance rate (= free hormone clearance rate) of T3 exceeds that of T4 by a factor 1.8 in the rat. The corresponding ratio in man, 2.4, was determined by noncompartmental analysis of turnover studies in four individuals after the simultaneous injection of T4-125I and T3-131I. The greater cellular metabolic clearance rate of T3 both in rat and man may be related to the higher specific hormonal potency of this iodothyronine.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1016
page 1016
icon of scanned page 1017
page 1017
icon of scanned page 1018
page 1018
icon of scanned page 1019
page 1019
icon of scanned page 1020
page 1020
icon of scanned page 1021
page 1021
icon of scanned page 1022
page 1022
icon of scanned page 1023
page 1023
icon of scanned page 1024
page 1024
Version history
  • Version 1 (May 1, 1970): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts